PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers - Archive ouverte HAL Accéder directement au contenu
Poster De Conférence Année : 2017

PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (5) , (8) , (9) , (10) , (1) , (6) , (11) , (12)
1
2
3
4
5
6
7
8
9
10
11
12

Dates et versions

hal-01685153 , version 1 (16-01-2018)

Identifiants

Citer

V. Vendrely, C. Lemanski, E. Le Prise, E. Maillard, X. Mirabel, et al.. PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers. ESTRO 36, May 2017, Vienne, Austria. , Radiotherapy and Oncology, 123 (Supplement 1), pp.S367 - S368, 2017, ESTRO 36, May 5-9, 2017, Vienna, Austria. ⟨10.1016/S0167-8140(17)31139-8⟩. ⟨hal-01685153⟩
44 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More